Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

HIV treatment news

Show

From To
High blood concentrations of efavirenz associated with poor sleep

High blood concentrations of efavirenz (SustivaTM) are correlated with poor sleep, according to a Spanish study published to be published in the February 1st edition

Published
14 January 2004
By
Michael Carter
Review of experience in delivering ARVs in resource-limited settings now available

The World Health Organisation has published a detailed review of experience in delivering antiretroviral therapy in resource-limited settings. The guide, produced by the UK Department

Published
09 January 2004
By
Keith Alcorn
NNRTI therapy associated with better sexual satisfaction

HAART regimens containing non-nucleoside analogues (NNRTIs) are associated with improvements in sexual satisfaction, according to an Italian prospective quality of life study published in the

Published
06 January 2004
By
Michael Carter
Roche stalls second generation fusion inhibitor, citing formulation problems

Roche today announced that a successor to its fusion inhibitor T-20 (Fuzeon) may be much further off than expected, following the discovery that the current

Published
06 January 2004
By
Keith Alcorn
HIV patients with severe immune damage have incomplete immune recovery - but does it matter?

HIV-positive individuals who started HAART when they have very severe immune damage may have impaired immune reconstitution, even if their CD4 cell count recovers enough

Published
06 January 2004
By
Michael Carter
More evidence that earlier treatment provides greatest benefit for children with HIV

In HIV positive children, starting antiretroviral therapy at younger ages and before severe immune suppression occurs appears to promote better CD4 cell recovery, according to

Published
01 January 2004
By
Liz Highleyman
Looking forward to 2004: microbicide and ARV prevention prospects

Several would-be microbicides are due for large-scale clinical trials in 2004, testing two basic ideas about how to protect women from HIV through vaginal sex.

Published
31 December 2003
By
Julian Meldrum
Looking forward to 2004: HIV vaccine prospects

In 2003, the first preventive vaccines to go into full scale trials were shown conclusively not to work. It is unlikely that anything as clear

Published
30 December 2003
By
Julian Meldrum
Looking forward to 2004: treatment for hepatitis C

Hepatitis C treatment has moved forward subtantially in the past two years with the widespread adoption of combination therapy with pegylated interferon and ribavirin. What

Published
29 December 2003
By
Daniel Raymond
US doctors plan cross the board Abbott product boycott after 400% ritonavir price hike

Abbott Laboratories is facing mounting criticism following its decision to quadruple the price of ritonavir Norvir in the United States. The company emphasises that the

Published
18 December 2003
By
Keith Alcorn

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.